Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina

Nutrients

Volumn 9, Issue 10, 2017, Pages

  Al Dosari, Dalia I ^a   Ahmed, Mohammed M ^b   Al Rejaie, Salim S ^b   Alhomida, Abdullah S ^a   Ola, Mohammad S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Apoptosis; Diabetic retinopathy; Flavonoid; Naringenin; Neurotrophic factor; Oxidative stress

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; APOPTOSIS INHIBITOR; BETA ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CASPASE 3; GLUCOSE; GLUTATHIONE; INSULIN; NARINGENIN; NEUROTROPHIC FACTOR; PROTEIN BAX; PROTEIN BCL 2; SYNAPTOPHYSIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; FLAVANONE DERIVATIVE; FLAVONOID; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS ASSAY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; RETINA INJURY; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BLOOD; DISEASE MODEL; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; RETINA; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD GLUCOSE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FLAVANONES; FLAVONOIDS; GLUTATHIONE; HYPOGLYCEMIC AGENTS; MALE; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; SYNAPTOPHYSIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 85032295874     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9101161     Document Type: Article

References (52)

1. Kern, T.S. Interrelationships between the retinal neuroglia and vasculature in diabetes. Diabetes Metab. ]. 2011, 38,163-170.
2. Ola, M.S.; Nawaz, M.I.; Khan, H.A.; Alhomida, A.S. Neurodegeneration and neuroprotection in diabetic retinopathy. Int. J. Mol. Sci. 2013,14, 2559-2572.
3. Feng, Y.; Wang, Y.; Stock, O.; Pfister, F.; Tanimoto, N.; Seeliger, M.W.; Hillebrands, J.L.; Hoffmann, S.; Wolburg, H.; Gretz, N.; et al . Vasoregres sion linked to neuronal damage in the rat with defect of polycystin-2. PLoS ONE 2009, 4, e7328.
4. Moran, E.P.; Wang, Z.; Chen, J .; Sapieha, P.; Smith, L.E.; Ma, J.X. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications. Am. ]. Physiol. Heart Circ. Physiol. 2016, 311, 738-749.
5. Barber, AJ.; Lieth, E.; Khin, S.A.; Antonetti, D.A.; Buchanan, A.G.; Gardner, T.W. Neural apoptosis in the retina during eaperimental and human diabetes. Early onsei and effect of insulin. J. Clin. Investig. 1998, 102, 783-791.
6. Kowluru, R.A.; Chan, P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, 2007, 43603.
7. Ola, M.S.; Berkich, D.A.; Xu, Y.; King, M.T.; Gardner, T.W.; Simpson, I.; LaNoue, K.F. Analysis of glucose metabolism in diabetic rat retinas. Am. J. Physiol. Endocrinol. Metab. 2006, 290, 1057-1067.
8. Ola, M.S.; Nawaz, M.I.; Siddiquei, M.M.; Al-Amro, S.; Abu El-Asrar, A.M. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J. Diabetes Complicat. 2012, 26, 56-64.
9. Li, C.; Miao, X.; Li, F.; Wang, S.; Liu, Q.; Wang, Y. Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy. Oxid. Med. Cell. Longev. 2017, 2017, 9702820.
10. Ola, M.S.; Alhomida, A.S. Neurodegeneration in diabetic retina and its potential drug targets. Curr. Neuropharmacol. 2014, 12, 380-386.
11. Ola, M.S.; Ahmed, M.M.; Ahmad, R.; Abuohashish, H.M.; Al-Rejaie, S.S.; Alhomida, A.S. Neuroprotective effects of rutin in streptozotocin-induced diabetic rat retina. J. Mol. Neurosci. 2015, 56, 440-448.
12. Ryter, S.W.; Kim, H.P.; Hoetzel, A.; Park, J.W.; Nakahira, K.; Wang, X.; Choi, A.M. Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 2007, 9, 49-89.
13. Park, K.S.; Kim, S.S.; Kim, J.C.; Kim, H.C.; Im, Y.S.; Ahn, C.W.; Lee, H.K. Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am. J. Ophthalmol. 2008, 145, 432-437.
14. Seki, M.; Tanaka, T.; Nawa, H.; Usui, T.; Fukuchi, T.; Ikeda, K.; Abe, H.; Takei, N. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: Therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 2004, 53, 2412-2419.
15. Sasaki, M.; Ozawa, Y.; Kurihara, T.; Kubota, S.; Yuki, K.; Noda, K.; Kobayashi, S.; Ishida, S.; Tsubota, K. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 2010, 53, 971-979.
16. Ola, M.S.; Aleisa, A.M.; Al-Rejaie, S.S.; Abuohashish, H.M.; Parmar, M.Y.; Alhomida, A.S.; Ahmed, M.M. Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol. Sci. 2014, 35, 1003-1008.
17. Ola, M.S.; Nawaz, M.I.; El-Asrar, A.A.; Abouammoh, M.; Alhomida, A.S. Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell. Mol. Neurobiol. 2013, 33, 359-367.
18. Krabbe, K.S.; Nielsen, A.R.; Krogh-Madsen, R.; Plomgaard, P.; Rasmussen, P.; Erikstrup, C.; Fischer, C.P.; Lindegaard, B.; Petersen, A.M.; Taudorf, S.; et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50, 431-438.
19. Teng, H.K.; Teng, K.K.; Lee, R.; Wright, S.; Tevar, S.; Almeida, R.D.; Kermani, P.; Torkin, R.; Chen, Z.Y.; Lee, F.S.; et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25, 5455-5463.
20. Kumar, B.; Gupta, S.K.; Srinivasan, B.P.; Nag, T.C.; Srivastava, S.; Saxena, R.; Jha, K.A. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc. Res. 2013, 87, 65-74.
21. Li, D.; Yang, F.; Cheng, H.; Liu, C.; Sun, M.; Wu, K.; Ai, M. Protective effects of total flavonoids from Flos Puerariae on retinal neuronal damage in diabetic mice. Mol. Vis. 2013, 19, 1999-2010.
22. Silva, K.C.; Rosales,M.A.; Hamassaki, D.E.; Saito, K.C.; Faria, A.M.; Ribeiro, P.A.; Faria, J.B.; Faria, J.M. Green tea is neuroprotective in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2013, 54, 1325-1336.
23. Al-Dosary, D.I.; Alhomida, A.S.; Ola, M.S. Protective effects of dietary flavonoids in diabetic induced retinal neurodegeneration. Curr. Drug Targets 2017. 18, 1468-1476.
24. Heo, H.J.; Kim, D.O.; Shin, S.C.; Kim, M.J.; Kim, B.G.; Shin, D.H. Effect of antioxidant flavanone, naringenin, from citrus Jonson neuroprotection. J. Agric. Food Chem. 2004, 52, 1520-1525.
25. Ortiz-Andrade, R.R.; Sánchez-Salgado, J.C.; Navarrete-Vázquez, G.; Webster, S.P.; Binnie, M.; García-Jiménez, S.; León-Rivera, I.; Cigarroa-Vázquez, P.; Villalobos-Molina, R.; Estrada-Soto, S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab. 2008, 10, 1097-1104.
26. Al-Rejaie, S.S.; Abuohashish, H.M.; Al-Enazi, M.M.; Al-Assaf, A.H.; Parmar, M.Y.; Ahmed, M.M. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J. Gastroenterol. 2013, 19, 5633-5644.
27. Raza, S.S.; Khan, M.M.; Ahmad, A.; Ashafaq, M.; Islam, F.; Wagner, A.P.; Safhi, M.M.; Islam, F. Neuroprotective effect of naringenin is mediated through suppression of NF-kB signaling pathway in experimental stroke. Neuroscience 2013, 230, 157-171.
28. Kara, S.; Gencer, B.; Karaca, T.; Tufan, A.H.; Arikan, S.; Ersan, I.; Karaboga, I.; Hanci, V. Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. Sci. World J. 2014, 2014, 1-8.
29. Al-Rejaie, S.S.; Aleisa, A.M.; Abuohashish, H.M.; Parmar, M.Y.; Ola, M.S.; Al-Hosaini, A.A.; Ahmed, M.M. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurol. Res. 2015, 37, 924-933.
30. Lowry, O.H.; Rosebough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
31. Sedlak, J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 1968, 25, 192-205.
32. Fort, P.E.; Losiewicz, M.K.; Reiter, C.E.; Singh, R.S.; Nakamura, M.; Abcouwer, S.F.; Barber, A.J.; Gardner, T.W. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: Evidence for retinal insulin resistance. PLoS ONE 2011, 6, e26498.
33. Priscilla, D.H.; Roy, D.; Suresh, A.; Kumar, V.; Thirumurugan, K. Naringenin inhibits a-glucosidase activity:A promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem. Biol. Interact. 2014, 210, 77-85.
34. Li, J.M.; Che, C.T.; Lau, C.B.S.; Leung, P.S.; Cheng, C.H.K. Inhibition of intestinal andrenal Na+-glucose co-transporter by naringenin. Int. J. Biochem. Cell Biol. 2006, 38, 985-995.
35. Bhattacharya, S.; Oksbjerg, N.; Young, J.F.; Jeppesen, P.B. Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes. Metab. 2014, 16, 602-612.
36. Payne, A.J.; Kaja, S.; Naumchuk, Y.; Kunjukunju, N.; Koulen, P. Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina. Int. J. Mol. Sci. 2014, 15, 1865-1886.
37. Rahigude, A.; Bhutada, P.; Kaulaskar, S.; Aswar, M.; Otari, K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience 2012, 226, 62-72.
38. Roy, S.; Ahmed, F.; Banerjee, S.; Saha, U. Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events. Pharm. Biol. 2016, 54, 1616-1627.
39. Carrasco, E.; Hernández, C.; Miralles, A.; Huguet, P.; Farrés, J.; Simó, R. Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 2007, 30, 2902-2908.
40. Mohr, S.; Xi, X.; Tang, J.; Kern, T.S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51, 1172-1179.
41. Xu, X.H.; Ma, C.M.; Han, Y.Z.; Li, Y.; Liu, C.; Duan, Z.H.; Liu, D.Q.; Liu, R.H. Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells. Arch. Biol. Sci. 2015, 67, 639-646.
42. Lim, W.; Song, G. Naringenin-induced migration of embrynoic trophectoderm cells is mediated via PI3K/AKT and ERK1/2 MAPK signaling cascades. Mol. Cell. Endocrinol. 2016, 428, 28-37.
43. Yoshii, A.; Constantine-Paton, M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev. Neurobiol. 2010, 70, 304-322.
44. Gupta, V.K.; You, Y.; Gupta, V.B.; Klistorner, A.; Graham, S.L. TrkB receptor signalling: Implications in neurodegenerative, psychiatric and proliferative disorders. Int. J. Mol. Sci. 2013, 14, 10122-10142.
45. Mohamed, R.; El-Remessy, A.B. Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy. J. Clin. Exp. Ophthalmol. 2015, 6, 483.
46. Al-Gayyar, M.M.; Matragoon, S.; Pillai, B.A.; Ali, T.K.; Abdelsaid, M.A.; El-Remessy, A.B. Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes. Diabetologia 2011, 54, 669-680.
47. Xu, S.L.; Bi, C.W.; Choi, R.C.; Zhu, K.Y.; Miernisha, A.; Dong, T.T.; Tsim, K.W. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: A signaling response mediated by estrogen receptor. Evid. Based Complement. Alternat. Med. 2013, 2013, 127075.
48. Zhan, S.S.; Beyreuther, K.; Schmitt, H.P. Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 1993, 4, 66-74.
49. Kwon, S.E.; Chapman, E.R. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 2011, 70, 847-854.
50. Kurihara, T.; Ozawa, Y.; Nagai, N.; Shinoda, K.; Noda, K.; Imamura, Y.; Tsubota, K.; Okano, H.; Oike, Y.; Ishida, S. Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina. Diabetes 2008, 57, 2191-2198.
51. Orbán-Gyapai, O.; Raghavan, A.; Vasas, A.; Forgo, P.; Hohmann, J.; Shah, Z.A. Flavonoids isolated from Rumex aquaticus exhibit neuroprotective and neurorestorative properties by enhancing neurite outgrowth and synaptophysin. CNS Neurol. Disord. Drug Targets 2014, 13, 1458-1464.
52. Zhang, L.; Zhao, Q.; Chen, C.H.; Qin, Q.Z.; Zhou, Z.; Yu, Z.P. Synaptophysin and the dopaminergic system in hippocampus are involved in the protective effect of rutin against trimethyltin-induced learning and memory impairment. Nutr. Neurosci. 2014, 17, 222-229.